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Abstract
Failure of axons to regenerate following acute or chronic neuronal injury is attributed to both the inhibitory glial
environment and deficient intrinsic ability to re-grow. However, the underlying mechanisms of the latter remain unclear. In
this study, we have investigated the role of the mammalian homologue of aspergillus nidulans NudE, Ndel1, emergently
viewed as an integrator of the cytoskeleton, in axon regeneration. Ndel1 was synthesized de novo and upregulated in
crushed and transected sciatic nerve axons, and, upon injury, was strongly associated with neuronal form of the
intermediate filament (IF) Vimentin while dissociating from the mature neuronal IF (Neurofilament) light chain NF-L.
Consistent with a role for Ndel1 in the conditioning lesion-induced neurite outgrowth of Dorsal Root Ganglion (DRG)
neurons, the long lasting in vivo formation of the neuronal Ndel1/Vimentin complex was associated with robust axon
regeneration. Furthermore, local silencing of Ndel1 in transected axons by siRNA severely reduced the extent of
regeneration in vivo. Thus, Ndel1 promotes axonal regeneration; activating this endogenous repair mechanism may
enhance neuroregeneration during acute and chronic axonal degeneration.
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Introduction
Axonal injury, the underlying cause of spinal cord disability,
neuropathies and neurodegenerative disorders, triggers changes in
gene expression and protein complexes within neurons and glia.
While some of these changes favor axonal regeneration, other
signals drastically dampen the protective response, resulting in
either failed or incomplete functional recovery. For instance,
myelin-associated proteins and chondroitin sulfate proteoglycans
impede axonal re-growth while neurotrophin retrograde signaling
elicits neuronal survival [1–5].
Dynamic changes in axon structure constitute another critical
path for nerve regeneration that can be triggered by modulation of
the cytoskeleton, a highly organized architectural network
composed of microtubules (MTs), intermediate filaments (IFs),
microfilament (MFs) and their associated proteins [6–10].
Following neuronal injury, the developmental pattern of IFs
resumes: IF proteins that decline during development are re-
expressed [11–17]. This change in gene expression is thought to
contribute to neuronal plasticity during regeneration. Neverthe-
less, the mechanisms of cytoskeletal remodeling within injured
axons remain poorly defined.
Ndel1, the mammalian homologue of the Aspergillus nidulans
NudE, is emergently viewed as an integrator and stabilizer of the
cytoskeleton. In migrating neurons of the developing cortex, Ndel1
regulates MT dynamics and centrosome-nucleus coupling [18]. In
mature CNS neurons, Ndel1 regulates Neurofilaments (NFs)
assembly and homeostasis via a direct association with NF light
chain (NF-L), thereby impacting neuronal survival [19]. Ndel1
also contributes to neurite outgrowth in PC-12 cells through
interactions with the Disrupted-in-Schizophrenia protein1 (DISC-
1) and Fez1 [20–22]. Recently, we found that Nde1l forms a
molecular complex with the IF Vimentin and regulates Vimentin
dynamics during neurite extension in CAD cells [23]. Vimentin
also promotes neurite outgrowth in neuroblastoma and isolated
primary neurons [24–27]. Consistently, Vimentin favors axon
regeneration when present in neurons and Vimentin null mice
exhibit impaired recovery of sensory response and reduced
regeneration 6 days after sciatic nerve crush [27]). Nevertheless,
Vimentin also displays anti-regenerative properties when ex-
pressed in glial cells [28–31]. Whether Ndel1 contributes to or
impedes axon regeneration in vivo in association with Vimentin
remains unknown.
We now discover that Ndel1 is upregulated at the mRNA and
protein levels in injured axons in vivo and during regeneration, it
preferentially associates with neuronal Vimentin. Remarkably, in a
lesion induced neurite outgrowth assay of DRG neurons, and in
rat models of sciatic nerve crush and transection, Ndel1 promotes
PLoS ONE | www.plosone.org 1 April 2008 | Volume 3 | Issue 4 | e2014axon regeneration. We propose that Ndel1 mediates regeneration
via neuronal IFs.
Results
Axonal localization of the Ndel1/Vimentin complex
Ndel1 and Vimentin contribute to neurite outgrowth, a read-
out for axonal regeneration [20–22,24–26]. Recently, we found
that Ndel1 associates with Vimentin during neurite extension [23].
In vivo, Vimentin is expressed in both glia and neurons and
therefore, the IF exhibits both pro- and anti-regenerative
properties. To better understand the role of Ndel1 following
axonal injury, we first determined the in vivo distribution of the
Ndel1/Vimentin complex in nervous tissues (spinal cord, dorsal
root ganglion (DRG) and sciatic nerve). As detected by confocal
microscopy, Ndel1 protein was strongly enriched in DRG neurons
and small and large NF-positive axons of spinal cord and sciatic
nerve (Fig. 1A and 1B, 1
st row). Double in situ hybridization/
immunohistochemistry with NF antibody further confirmed that
Ndel1 mRNA was strongly expressed in DRG neurons (Fig. 1C).
No in situ signal was found with the control sense probe (data not
shown). Importantly, Ndel1 co-localized with Vimentin in a subset
of small-diameter axons in these tissues but not with the Vimentin
in the basal lamina of glial cells (Fig. 1B, 2
nd and 3
rd row).
Consistent with the enriched localization of Ndel1 in neurons,
Ndel1 antibodies conjugated to gold particles decorated the IF
structures within sciatic nerve axon but were absent from myelin of
Schwann cells (Fig. 1D).
To seek further evidence for an in vivo association between
Ndel1 and neuronal Vimentin in neurons, we isolated axoplasms
and axonal preparations from sciatic nerve and spinal cord,
respectively. We took advantage of the neuronal pattern of
expression of Ndel1 and performed co-immunoprecipitations on
the preparations with Ndel1 antibodies in detergent-free buffers
(see Material and Methods). In these conditions, Vimentin nicely
co-immunoprecipitated with Ndel1 from PBS-isolated axoplasm
of sciatic nerves (Fig. 1E). Furthermore, Vimentin also co-
purified with Ndel1 in axonal cytoskeletal preparations from
spinal cord and co-immunoprecipitated with Ndel1 in these
preparations (Fig. 1F). The direct interaction between Ndel1 and
Vimentin was demonstrated by an in vitro binding assay using
purified His-Ndel1 and GST-Vimentin proteins. While His-beads
did not pull down GST-Vimentin, His-Ndel1 pulled down GST-
Vimentin (Fig. 1G). Taken together, these results indicate that
Ndel1 and Vimentin selectively co-associate in a subset of axons
in vivo. Of note, the Vimentin antibody detected a lower
molecular band that may correspond to a hypophosphorylated
form of the protein. It is also noteworthy that Peripherin,
another IF expressed in neurons and involved in axon outgrowth
and regeneration [13], did not co-immunoprecipitate and did not
co-fractionate with Ndel1 in significant amount in spinal cord
and nerves (Fig. S1). Based on the selective presence of Ndel1/
Figure 1. Axonal localization of Ndel1/Vimentin complex. (A) and (B) In vivo expression of Ndel1 in DRG neurons, large diameter NF-positive
axons and small diameter Vimentin-positive axons but not in the Vimentin-positive basal lamina of glial cells. (C) Double in situ hybridization/
immunohistochemistry depicting the expression of Ndel1 mRNA in NF-positive DRG neurons in vivo. (D) Immunogold labeling depicting the presence
of Ndel1 on intermediate filament within the axon and its absence from myelin sheet. (E) Vimentin co-immunoprecipitates with Ndel1 in axoplasm.
(F) Ndel1 and Vimentin co-fractionate in axonal cytoskeletal preparations. Vimentin co-immunoprecipitates with Ndel1 in axonal cytoskeletal
preparation. The lower molecular form of Vimentin does not co-immunoprecitate with Ndel1 and may represent a hypophosphorylated form of the
protein. All co-immunoprecipitations were performed using Ndel1 antibodies. No antibodies and GFP antibodies were used as negative controls. Pre-
cleared fractions 1 and 2 contain non-axonal proteins (from cell body or other non-neuronal cells). (G) In vitro binding assay using purified His-Ndel1
and GST-Vimentin proteins. His-Ndel1 but not His-beads (negative control) pulls down GST-Vimentin.
doi:10.1371/journal.pone.0002014.g001
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determined whether the formation of the complex is enhanced
following sciatic nerve crush and transection.
Upregulation of neuronal Ndel1/Vimentin complex
correlates with regeneration after sciatic nerve crush
Following sciatic nerve crush or transection, Vimentin is
upregulated in both glial cells and injured axons/neurons at the
mRNA and protein levels [12,14–17,27]. Using RT-PCR and
Western blots, we first confirmed the upregulation of Vimentin
within hours following sciatic nerve crush in rats. From 3 and
12 hours after injury, Ndel1 and Vimentin mRNAs and soluble
proteins were synthesized and up-regulated in both distal and
proximal stumps of injured nerves, when compared to the
contralateral non-injured sides (Fig. 2). While Vimentin full length
(FL) and reported truncated fragments were strongly upregulated,
the augmentation in levels of Ndel1 protein was modest (Fig. 2A
and 2B; Fig. S2 for quantification). The difference in upregulation
of Ndel1 and Vimentin mRNA vs protein levels suggests that
translation of these proteins is also regulated following sciatic nerve
injury. As revealed by double in situ hybridization/immunohisto-
chemistry, Ndel1 mRNAs were mostly found in NF-positive axons
(Fig. 2A), consistent with its neuronal pattern of expression (Fig. 1).
This is in contrast to Vimentin mRNAs that originate from both
injured axons and glial cells [12,14–17,27].
To determine whether the Ndel1/Vimentin complex forms in
injured axons, we again took advantage of the neuronal expression
pattern of Ndel1 and performed co-immunoprecipitations with
Ndel1 antibodies on sciatic nerve soluble lysates. We found that
truncated forms of Vimentin, but not the full length, co-
immunoprecipitated with Ndel1 at these early time points
(Fig. 2B; Fig. S2 for quantification). These truncated forms have
been suggested to participate in the early regenerative response
(see discussion and [5,27]).
Remarkably, the upregulation of Ndel1 and full length
Vimentin was strongly sustained in injured nerves even up to
two weeks after injury (Fig. 2C). The degree of augmentation in
Ndel1 levels also correlated with higher levels of GAP-43, a
neuronal marker for axonal regeneration, and with stabilization
of NF-L, a marker for advanced regeneration and maturation
(Fig. 2C). The stabilization of NF-L and increased GAP-43 did
not correlate with the formation of the truncated fragments of
Vimentin (Fig. 2C, graph). Importantly, in both proximal and
distal segment of injured nerves, enhanced formation of neuronal
Ndel1/Vimentin complex was observed after injury, as indicated
by immunoprecipitations with Ndel1 antibodies (Fig. 2D).
Highest levels of Ndel1/Vimentin in these co-immunoprecipi-
tates were found in nerve samples with the highest degree of
regeneration, as determined with levels of GAP-43 in total lysates
(Fig. 2D). To further confirm the enhanced formation of this
complex in axons, we isolated axoplasms from injured and non-
injured proximal nerves and performed co-immunoprecipitations
in detergent-free buffers (PBS or Tris-NaCl) using Ndel1
antibodies (see Material and Method). We found enhanced
formation of the Ndel1/Vimentin complex in proximal segments
of crushed nerves (Fig. 2E). The up-regulation of Ndel1 in
regenerating nerve axons was further verified by co-staining with
Neurofilament antibodies, followed by Z-stack sectioning on
confocal microscopy (Fig. 2F). Morphologically, the regenerating
axons often exhibited small diameter with higher Ndel1 content.
Together, these results indicated that formation of the neuronal
Ndel1/Vimentin complex is associated with axonal nerve
regeneration.
Upregulation of neuronal Ndel1/Vimentin complex
correlates with regeneration after sciatic nerve
transection
Next, we extended our findings to the ratsciatic nerve transection
model. Similar to the crush model, we observed synthesis and
upregulation of Ndel1 and full length Vimentin in both injured
distal and proximal nerve stumps when compared to the non-
injured contralateral sides (control) at 65 hours following sciatic
nerve transection (Fig. 3A and B). The upregulation of soluble
Ndel1 in injured nerves again led to enhanced formation of the
neuronal Ndel1/full length Vimentin complex, as determined by
co-immunoprecipitations with Ndel1 antibodies (Fig. 3B). The
formation of the complex was corroborated with increased levels of
GAP-43 specifically in the proximal fragment of the injured nerve
still connected to nerve cell bodies (Fig. 3B). To further confirm the
existence of this complex in axons, we isolated axoplasm from
injured and non-injured nerves (distal and proximal) and performed
co-immunoprecipitations in detergent-free buffers (PBS or Tris-
NaCl)using Ndel1antibodies. Again,we foundenhancedformation
of the Ndel1/Vimentin complex in injured axons, especially in the
proximal segment (Fig. 3C). Using Z-stack sections of confocal
microscopy, we further confirmed the upregulation of Ndel1 in
injured regenerating axons (Fig. 3D and Fig. S2). Thus, the results
obtained with both sciatic nerve crush and transection models
(Figs. 2 and 3) strongly indicated that formation of the neuronal
Ndel1/Vimentin complex is linked to axonal regeneration.
Ndel1 associates differentially with IFs following injury
During axon regeneration, the IF expression pattern exhibited
during neuronal differentiation resumes: Vimentin is re-upregu-
lated while the NF Light chain (NF-L), another Ndel1-interacting
protein in healthy axons, is downregulated [11–15,17,27,32]. This
change in IF expression is believed to favor plasticity of
regenerating axons. Based on this knowledge, we reasoned that
upon axotomy, Ndel1 will interact less with NF-L (in favor of
Vimentin) in tissues with higher regenerative potential.
We first confirmed the downregulation of NF-L proteins (62 to
68 kDa) in both distal and proximal segments of injured nerves
during the early stages of nerve axotomy (Fig. 4). Importantly, in
the proximal segment of injured nerves where enhanced neuronal
Ndel1/Vimentin association correlated with regeneration, there
was reduced association between soluble Ndel1 and NF-L proteins
when compared to the non-injured contralateral side (Fig. 4). In
contrast, in the distal segment where little regeneration occurs,
Ndel1 still associates with soluble NF-L proteins (Fig. 4). Together,
these results indicate that following injury, Ndel1 interacts
differentialy with soluble neuronal Vimentin and NF-L in nervous
tissues undergoing regeneration.
Silencing Ndel1 by RNAi in lesion conditioned DRG
neurons reduces neurite outgrowth
To examine the role of Ndel1 in axon outgrowth following
injury, we first investigated the conditioning lesion response of
isolated DRG neurons treated with an Alexa 488-conjugated
Ndel1 or control siRNA. We previously generated a specific
siRNA against Ndel1 to knockdown the protein in primary
neurons and mouse embryonic brains [18,19]. An Alexa 488-
conjugated scrambled sequence of siRNA without homology to
any known protein was used as control. Sciatic nerve transections
were performed 7 days prior to culture of neurons from L4/L5/L6
DRGs. Prelesioned conditioned neurons treated with Alexa 488-
conjugated Ndel1 siRNA for 24 hours in culture incorporated the
oligonucleotides (data not shown). Approximately 60% of cultured
Ndel1 in Nerve Regeneration
PLoS ONE | www.plosone.org 3 April 2008 | Volume 3 | Issue 4 | e2014Figure 2. Upregulation and enhanced association of Ndel1 with Vimentin during axon regeneration in a sciatic nerve crush model.
(A) Upregulation of Ndel1 and Vimentin in proximal stumps of crushed sciatic nerve 12 hours post-injury as revealed by RT-PCR. Quantification was
performed twice on 3 samples for each condition (control, proximal -3h and 12h- and distal -3h and 12h-). GAPDH was used as control. * P (T,t) two
tails: ,0.001. Double in situ hybridization/immunohistochemistry revealed the local synthesis of Ndel1 (dark blue) in injured NF-positive axons
(brown) 12h post injury. (B) Truncated fragment of Vimentin but not the full-length protein co-immunoprecipitates with Ndel1 early after injury (3–
12h) in proximal and distal segments of crushed sciatic nerve (n=5 for each condition). Note the early slight upregulation of Ndel1 protein versus the
strong up-regulation and degradation of Vimentin full length. See supplementary figure 2 for quantifications. (C) Efficient axonal regeneration 2
weeks post crush as detected by total levels of GAP-43, a regeneration marker, and the mature neuronal marker NF-L, in nerve samples with the
highest levels of Ndel1 and presence of full length (but not truncated) Vimentin (n=8 for nerves with full length Vimentin; n=5 for nerves with
truncated Vimentin). Note the lower levels of NF-L in samples with slower regeneration. (D) Enhanced association of Ndel1 with neuronal Vimentin
full length two weeks post-injury in nerve samples with robust regeneration as indicated by total levels of GAP-43 (n=5 for each condition). Co-
immunoprecipitations were performed with Ndel1 antibodies. (E) Enhanced association between Ndel1 and Vimentin in axoplasm of crushed nerves
isolated in two different buffers (n=5 for each condition). (F) Z-stack confocal pictures depicting the stronger co-localization of Ndel1 with small
Neurofilament-positive axons in injured proximal segments of sciatic nerve (one week post-injury) vs non-injured nerves (n=4). All co-ips were
perfomed with Ndel1 antibodies. All quantifications in B to E were standardized to levels of non-injured nerves (=basal level=1); for panels C-E: * P
(T,t) two tails: ,0.0001 (compared to basal level). For all experiments, ‘‘ n ’’ indicated the number of nerve sample from individual animal. Vim FL:
Vimentin full length; Vim TR: Vimentin truncated fragments; Ips: Immunoprecipitations; Inp: input.
doi:10.1371/journal.pone.0002014.g002
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positive DRG neurons express Ndel1. In these neurons, the two
proteins co-localize in the cell body and neurites (Fig. 5A).
Importantly, treatment of lesion-induced DRG neurons with
Ndel1 siRNA reduced the number of neurons undergoing neurite
outgrowth up to 50% as determined by staining with NF
antibodies (Fig. 5B). Furthermore, co-treatment of lesion-induced
DRG neurons with Ndel1 and Vimentin siRNAs did not further
reduce the number of neurons extending neurites (Fig. 5B). These
results indicated that Ndel1 is important for lesion-induced neurite
outgrowth of DRG neurons in vitro. Based on data indicating that
the two proteins associate together during neurite outgrowth [23],
these results suggested that Ndel1 works upstream or at least
serially with neuronal Vimentin in the same pathway.
Local silencing of Ndel1 by siRNA in injured nerves
reduces axon regeneration
To directly demonstrate a role for Ndel1 in in vivo axon
regeneration, we sought to silence locally Ndel1 by siRNA
following sciatic nerve transection. Using the ‘‘T’’ chamber with
the proximal stump connected to the distal stump [33,34], we
delivered the Alexa 488-conjugated Ndel1 siRNA to sectioned
nerve via the injection port beginning at 2 hours after injury, with
repeated injections 1, 3 and 5 days post injury (Fig. 6A). The mice
were analyzed one week post transection. The injection port
system has the advantage of locally silencing Ndel1 in injured
axons. This approach allows us to target selectively injured axons
and circumvents the early embryonic lethality of Ndel1 null mice.
As indicated by double labeling with a NF marker and confocal
Figure 3. Upregulation and enhanced association of Ndel1 with Vimentin during axon regeneration in a sciatic nerve transection
model. (A) Early upregulation of Ndel1 and Vimentin mRNAs in proximal and distal segments of transected sciatic nerve, 65 hours post-injury, as
revealed by RT-PCR. Quantification was performed twice on 3 samples for each condition (control, proximal, injured, non-injured). GAPDH was used
as control. * P (T,t) two tails: ,0.05. (B) Enhanced formation of the neuronal Ndel1/Vimentin complex correlated with upregulation of GAP-43 in the
proximal but not distal segment of transected nerve, 65 hours post-injury. Basal value=1 for non-transected nerves. N=5 for each condition. (C)
Enhanced formation of the Ndel1/Vimentin complex in axoplasm of proximal segment of transected nerves as determined by co-
immunoprecipitations with Ndel1 abs in two detergent-free buffers (PBS and Tris-NaCl). N=5 for each condition. Note the stronger association of
Ndel1 to Vimentin in axoplasm of proximal segment vs distal segment. Bar graph quantification is for the proximal segment. (D) Z-stack confocal
pictures depicting the light and robust co-localization of Ndel1 with Neurofilament-positive axons in non-injured and transected proximal segments
of sciatic nerve one week post-injury, respectively. All co-ips were perfomed with Ndel1 antibodies. Quantifications in panels B and C were
standardized to levels of non-injured nerves (=basal level=1); * P (T,t) two tails: ,0.0001 (compared to basal level). ‘‘ n ‘‘ represents the number of
nerve sample from individual animals. Inp: Input; Ips: co-mmunoprecipitations, c: control; Inj: injured; Prox: proximal; Dist: Distal.
doi:10.1371/journal.pone.0002014.g003
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were incorporated in the proximal stump of nerve axons (Fig. 6B).
Nerves unexposed to injections were negative for Alexa 488
detection (data not shown). Importantly, the Ndel1 siRNA
reduced by 50% the levels of Ndel1 protein indicated by western
blots (Fig. 6C and D). Moreover, the Ndel1 siRNA but not control
siRNA impeded axon regeneration as demonstrated by the
reduction in NF-positive fibers, consistent with the decreased
Alexa 488 signal (Fig. 6B). A remarkable downregulation of the
regeneration marker GAP-43 and Vimentin was also observed in
transected nerves injected with the Ndel1 siRNA (Fig. 6C and D).
Consistently, levels of Neurofilament H (NF-H), a late marker for
axonal maturation, were severely reduced in the Ndel1 siRNA-
injected nerves. Together, these results indicated that Ndel1 plays
a critical role in axon regeneration in vivo.
Finally, because Vimentin is expressed in both neuronal and
glial cells, the in vivo injection of the Vimentin siRNA would affect
both cell types. Therefore, there will be limitations in the
interpretation of results obtained with these injections as well as
co-injections of Ndel1/Vimentin siRNAs.
Discussion
Ndel1 is a new player in axon regeneration
The important role of Nde1l in neurite outgrowth and its
association with Vimentin, an IF with dual role in axon
regeneration, raised the question whether Ndel1 promotes or
impedes axon regeneration in vivo. Ndel1 knockout mice are
embryonic lethal [35] and therefore, can not be used to address
this question. Using the McDonald ‘‘T’’ chamber, we locally
silenced Ndel1 by siRNA in transected axons; we observed
decreased regeneration in vivo (Fig. 6) in a manner reminiscent of,
but to a more severe extent than sensory axons lacking Vimentin
[27]. This was demonstrated by a reduction in levels of Vimentin
and GAP-43, a marker for axonal regeneration, as well as NF-H, a
late marker for axonal maturation in Ndel1 siRNA treated nerves
(Fig. 6). It is unlikely that Ndel1 siRNA altered the Ndel1/
Vimentin complex in glial cells as Ndel1 mRNAs and protein were
found enriched in axons and neurons (Fig. 1). Furthermore, using
multiple biochemical and cellular methods, Ndel1 was found to
associate with Vimentin in axons (Figs. 2 and 3). If Ndel1 siRNA
reduced Vimentin functions in glial cells, one should expect to see
enhanced regeneration as Vimentin has anti-regeneration prop-
erties when expressed in glial cells [28–30,36]. However,
decreased regeneration associated with lowered levels of GAP-
43, Vimentin and NF-H was observed. Finally, silencing Ndel1 by
siRNA in conditioned lesion-induced DRG neurons also reduced
axon outgrowth (Fig. 5). These data support the ideas that Ndel1 is
in complex with Vimentin in axons and neurons and the Ndel1
Figure 4. Ndel1 interacts differentially with NF-L in tissues with
regenerative capability. NF-L isoforms interact less with Ndel1 in the
proximal (but not distal) segment, 65 hours post-injury. Note that NF-L
is downregulated in both segments after injury. Immunoprecipitations
were performed with Ndel1 antibodies. Experiment was repeated 3
times on 4 different sets of distant and proximal segments. All co-ips
were perfomed with Ndel1 antibodies. Quantifications were standard-
ized to levels of non-injured nerves (=basal level=1); * P (T,t) two
tails: ,0.001 (compared to basal level). Ips: co-mmunoprecipitations, c:
control; Inj: injured; Prox: proximal; Dist: Distal.
doi:10.1371/journal.pone.0002014.g004
Figure 5. Silencing Ndel1 by siRNA reduces lesion-conditioned
neurite outgrowth in DRG neurons. (A) Co-localization of Ndel1
and Vimentin in the cell body and neurites of nearly all Vimentin-
expressing DRG neurons. (B) Reduction of the conditioning lesion-
induced neurite outgrowth of isolated DRG neurons treated with Ndel1
siRNA. Co-treatment with Ndel1 and Vimentin siRNAs does not further
impede outgrowth. 5 to 7 different DRG cultures were performed and
the total number of neurons analyzed is indicated. Typical examples of
NF-positive DRG neuron with or without neurites are depicted. Note
that only DRG neurons with a normal nuclear morphology were
counted. * P (T,t) two tails: ,0.001, ** P (T,t) two tails: ,0.0001. Red:
NF; blue: DAPI.
doi:10.1371/journal.pone.0002014.g005
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Ndel1/Vimentin complex in non-neuronal cells, if any, would
have little effect on axon regeneration.
Mechanisms of actions of Ndel1 during axon
regeneration
By virtue of its association with molecular motors and its
modulation of MTs and IFs [18,19,21,22,37–41], Ndel1 may
remodel the cytoskeleton during axon regeneration. In our
experimental conditions of injury, IFs were the most affected.
Silencing Ndel1 by siRNA in injured axons significantly reduced
the levels of IFs but left significantly unchanged the levels of
Tubulin, Acetylated (stable) Tubulin, actin and the actin/MT-
associated proteins FAK and Lis1 (Fig. 6). Compensation by other
MT-associated factors may occur following injury.
During axon regeneration, the developmental pattern of IFs
resumes: Vimentin is re-upregulated and expression of mature IFs
such as NF-L and NF-H decreases [11–15,17,27,32]. Our in vitro
data suggested that Ndel1 works upstream of or at least serially
with neuronal Vimentin in the regenerative pathway as co-
silencing of Ndel1 and Vimentin does not further impede
outgrowth of lesion-conditioned DRG neurons when compared
to neurons treated with Ndel1 siRNA (Fig. 5). In tissues with
higher regenerative capacity, Ndel1 preferentially associates with
the neuronal form of Vimentin in detriment of NF-L. As
neuroregeneration is being completed and NFs are re-upregulated
to replace Vimentin, the ability of Ndel1 to associate with both
Vimentin and NFs may confer to this protein the unique capacity
to substitute IFs. For instance, through association with Vimentin
and NF-L, Ndel1 may favor the formation of NF/Vimentin
heteropolymers in injured axons, thereby serving as an initial site
for polymerization of Neurofilaments to rebuild the IF network
and stabilize the growing axons.
Of note, a recent study indicates that truncated fragments of
Vimentin form a complex with phosphorylated ERK, Importin
and Dynein and can elicit regeneration signals by scaffolding these
proteins [5,27]. We found that early hours after injury, Ndel1 co-
immunoprecipitates with these truncated fragments but ERK and
importins were not found in the co-precipitates (data not shown).
These data may suggest heterogeneity in the molecular compo-
sition of the Ndel1/Vimentin complex in cells. Importantly, in
nerves samples with slower regeneration, these truncated frag-
ments of Vimentin were more abundant than the full length
Vimentin. Our interpretation is that these fragments may
participate in signaling at early phase of regeneration (0–12 hours)
while the full length Vimentin acts at later stages of remodeling
(days).
Ndel1 and IFs null mice
The absence of phenotype in Vimentin null mice seems to argue
against a role for Ndel1/Vimentin in neurite outgrowth and axon
regeneration [42]. However, compensation for loss of Vimentin
may occur. Alternatively, the ubiquitous removal of Vimentin may
conceal the specific roles of neuronal Vimentin. For instance, in
vivo, Vimentin may promote neurite outgrowth in developing
neurons but may play an antagonistic role in other cell types;
Figure 6. Silencing locally Ndel1 in transected axons by siRNA decreases regeneration. (A) Injection of the Alexa 488-conjugated control
or Ndel1 siRNA usint the ‘‘T chamber’’ that connects the distal stump to the proximal stump. (B) Confocal picture showing the integration Alexa-488
control or Ndel1 siRNA in NF-positive axons of injected nerves. Note the reduced number of NF-positive fibers and dimmer Alexa 488 signal in the
Ndel1 siRNA-injected nerves, indicative of reduced surviving axons. (C) Silencing Ndel in proximal stumps of transected axons by local injection of
siRNA reduced expression of markers of regeneration (Vimentin, GAP-43) and axonal maturation (NF-H). Levels of Tubulin, Acetylated (stable),
Tubulin, Lis1 and actin remain similar. GAPDH was used as standard. (D) Graph quantification of the levels of Ndel1, Vimentin, GAP-43, NF-H, Tubulin,
Ac(etylated) Tubulin and Lis1 normalized with GAPDH or actin in arbitrary units. * P (T,t) two tails: ,0.05, ** P (T,t) two tails: ,0.001. Animals with
transected nerves and injected with Ndel1 siRNA=4; animals with transected nerves and injected with control (scramble) siRNA=3. Western blot
analysis was performed 3 times for each animal and condition (control and Ndel1 RNAi).
doi:10.1371/journal.pone.0002014.g006
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resulting in absence of overt phenotype.
Actually, Vimentin null mice exhibit subtle impaired recovery
of sensory response 6 days after sciatic nerve crush and reduced
levels of GAP-43, [27]. Mice lacking NF-L, another binding
partner for Ndel1 differentially regulated during axon regenera-
tion, exhibit delayed axon regeneration following sciatic nerve
crush [32]. The lack of overt phenotype in these knockout mice
strikingly contrasts with the embryonic lethality of Ndel1 null
mice [35]. The essential role of Ndel1 during development and
regeneration would be consistent with its upstream regulation on
both Vimentin and NFs.
Conclusion
In summary, our study reveals that Ndel1 is important player in
axonal regeneration in vivo. Modulation of this pathway by
upstream signals derived from both neurons and glia holds great
promise to promote nerve regeneration For instance, the Ndel1
gene is controlled by CREB, a transcription factor that regulates
neuronal activity and is induced during nerve injury for
neuroprotection [43,44]. In addition, pharmacological strategies
aiming to manipulate the dynamics of neuronal Vimentin via
Ndel1 may also directly contribute to intrinsic axonal growth
during nerve regeneration.
Materials and Methods
Biochemistry
Total protein extracts of mouse spinal cord, sciatic nerve (distal,
proximal stumps) were obtained by homogenization in SDS-urea
b-mercaptoethanol (0.5% SDS, 8M urea in 7.4 phosphate buffer),
Triton X-100 (10mM Tris-HCl [pH 7.5], 150 mM NaCl, 1 mM
EDTA [pH 8.0], and 1% Triton) or E1A lysis buffer (50 mM Tris-
HCl [pH 7.5], 250 mM NaCl, 5 mM EDTA [pH 8.0], and 0.1%
Nonidet P-40) with a cocktail of protease inhibitors (PMSF,
leupeptin, pepstatin, apoprotinin). For the soluble fraction, tissues
were gently homogenized in the above buffers without detergent
and the supernatant was collected after centrifugation at 10,000 g
for 20 min or 15 min. Isolation of axoplasm was performed in
detergent-free buffers (PBS or Tris-NaCl) by gently squeezing
sciatic nerves and spinal cord as reported in[27]. The protein
concentration was estimated by the Bradford procedure (Bio-Rad
Laboratories, Hercules, CA). Immunoprecipitations were per-
formed from isolated axoplasms in PBS or Tris-NaCl, cytoskeletal
preparations and solubles fraction of spinal cord and sciatic nerves
in the above described buffers without detergents (no SDS, Triton,
Nonidet P-40). Proteins (20 to 50 mg) were fractionated on 7.5%
SDS-PAGE and blotted on a nitrocellulose or PVDF membrane
for western blot analysis. ) In vitro binding assay using purified His
(1 mg), His-Ndel1 (1 mg) and GST-Vimentin (0,5 mg) proteins were
performed according to [19]. Membranes were incubated with
antibodies against Ndel1 (210, 211) [18,19], Dynein intermediate
chain (MAB 1618, Chemicon), actin (C4, MAB1501, Chemicon),
Vimentin (Abcam, Chemicon), Peripherin (Chemicon), FAK (N-
20, Santa Cruz Biotechnology), Acetylated-Tubulin (Abcam),
Tyrosinated Tubulin (Abcam), GAP-43 (Abcam), Neurofilament
light chain (Chemicon, Covance). The western blots were revealed
by chemiluminescence (RENAISSANCE, Western blot kit, NEN
Life Science (Boston, MA)).
RNA isolation, RT-PCR and in situ hybridization
Total RNA samples from non-injured and injured sciatic nerve
tissues (proximal and distal segments, with or without Ndel1 RNAi
treatment) were isolated using the TRIzol Regent (Invitrogen)
according to the manufacturer’s instructions. The complementary
DNA (cDNA) was reversely transcribed from same concentrations
of total RNA products using random hexamers and M-MLV
reverse-transcriptase (Promega). Quantitation of transcripts from
the samples was performed by PCR with GAPDH primer. Each
gene (Ndel1, Vimentin, GAP-43, and GAPDH) was amplified for
33cycles. 10 ml aliquots of PCR products were electrophoresed on
a 1.5 % agarose gel in Tri-acetate-EDTA (TAE) buffer and
visualized by staining with etidium bromide (EtBr). Primers for
Ndel1, Vimentin, GAP-43, and GAPDH, are: Ndel1 up 59
gcaggctgataaccaaagac 39, Ndel1 dn 59 ccgcagaatccatcttctc 39,
Vimentin up 59 agatcgatgtggacgtttcc 39, Vimentin dn 59
tcttccatttcacgcatctg 39, GAP-43 up 59 ggctctgctactaccgatgc 39,
GAP-43 dn 59 ctgtcgggcactttccttag 39, GAPDH up 59
gtgttcctacccccaatgtg 39, GAPDH dn 59 tgtgagggagatgctcagtg 39.
In situ hybridization using digoxigenin-labeled RNA probes was
performed as described previously [45]. 16 mm DRG cryosections
were fixed in 4% PFA and washed twice in PBT(PBS with 0.1%
Tween-20). After bleaching with 6% H2O2/PBT and washing,
sections were treated with 1 mg/ml proteinase K/PBT. Then
sections were refixed and washed in PBT prior to hybridization
overnight at 70uC. Sections were washed three times in 50%
formamid/5xSSC/1%SDS at 70uC, followed by two washes in
50% formamid/2xSSC at 65uC. Staining was visualized using an
NBT/BCIP (Roche) substrate.
Generation, characterization of siRNA sequences and
RNAi vectors
RNAi sequences were selected based on the criteria proposed by
[46]. Complementary hair pin sequences or oligonucleotides were
commercially synthesized and cloned into pSilencer 2.0 under
promoter U6 (Ambion). Sequence for Ndel1 are base pair (bp)
276-294 (GCAGGTCTCAGTGTTAGAA) [18,19]. A random
sequence without homology to any known mRNA was used for
control RNAi. All RNAi constructs were tested in 3T3 cells, CAD
cells and primary neurons by both western blot and immunocy-
tochemical staining. CAD cells were transfected with Lipofecta-
mine 2000 (Invitrogen).
DRG isolation and culture
L4/L5/L6 DRG neurons isolation was performed according to
[47]. Briefly, DRGs were excised and roots and membranes were
removed. After washing three times in cold L15, the DRGs were
incubated for 1.5 hours at 37uC in L15 containing 1 mg of
collagenase per ml. After pipetting the solution many times, the
solution was centrifuged at 800 rpm for 5 minutes, followed by
three washes in L15. Cells were resuspended in 1 ml of L15, and
passed through a 70 micron mesh. Then the cell solution was
loaded gently onto 2 ml of 15% BSA in L15 and centrifuged at
900 rpm for 10 minutes. The pellet cells were washed once in L15,
and resuspended in advanced DMEM-F12 medium containing
1% N-2 supplement and 1% penicillin/streptomycin. Finally, cells
were plated immediately on 6-well plate, previously coated with
poly-L-lysine (0.1mg/ml). The plate was maintained in an
incubator at 37uC with 5% CO2.
Sciatic nerve transection and crush
65 Male Sprague-Dawley rats weighing 250-300g were used as
an in vivo model for nerve regeneration. All procedures were
approved by the Animal Care Committee of the University of
Calgary in accordance with the Canadian Council on Animal
Care. Sciatic nerve transection was performed at mid-thigh level
on the left side under anesthesia with pentobarbital (65mg/kg,
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the rats undergoing this injury, as described below. Rats were
given analgesic (butorphanol, 2mg/kg, subcutaneous injection) at
0.5–1 and four hours after the surgery to prevent autotomy and
suture opening. Three days post surgery (72 hours), nerve tissues
(proximal/distal stumps, 0.5–1 cm), the 5
th lumbar dorsal root
ganglia (DRG), and the spinal cord dorsal column at the L5 spinal
level) were harvested from both the transectioned and the
untouched contralateral sides. Tissues to be used for mRNA
detection were placed in Trizol , while tissues to be used for
protein isolation and quantification were fresh frozen in liquid
nitrogen. In both of these cases, tissues were maintained at 280
degrees Celsius post-harvest. Tissues to be used for immunohis-
tochemistry, consisting of the proximal and distal segments of
sciatic nerves were placed into Zamboni’s fixative (2.0% PFA,
15% picric acid, 0.1 M sodium phosphate buffer, pH 7.3) or PBS
PFA 4% overnight. The nerves were then washed three times in
phosphate-buffered saline (PBS) and placed inside Cryomolds
(Tissue-Tek). Then, the specimens were covered in Optimal
Cutting Temperature compound (OCT, Tissue-Tek) and frozen at
280uC for at least one hour and kept frozen thereafter. In a
second surgery, five rats had the left sciatic nerve crushed twice in
succession, at angles perpendicular to one another, each for 30 s
(total of 60 s) at a site 20 mm proximal to the trifurcation of the
sciatic nerve branching, using a hemostat forceps. The site of
injury was marked with a non-absorbent suture in adjacent muscle
for later site identification. Animals were monitored post-
operatively for signs of infection or other complications of surgery.
Tissues were harvested as described above. Tissues were
immediately processed for mRNA, protein isolation and immu-
noprecipitation. Tissues were processed as described above.
For later immunohistochemical investigations embedded nerves
were cut into 14 mm sections using a cryostat (HM500, Microm) at
225uC and placed onto glass slides (SuperFrost White, VWR). On
the day of staining, the tissues were post-fixed for 30 min at room
temperature in 4 % paraformaldehyde in PBS, pH 7.4. After
washing with PBS, the sections were incubated for 2 hr with
blocking solution (PBS containing 3 % BSA and 0.2 % Triton X-
100, pH 7.4). After rinsing, they were incubated overnight at 4
degrees Celsius in a humidified chamber with primary antibodies
diluted in blocking solution. After washes with PBS, the sections
were incubated for 2 hr with secondary antibodies (Jackson
Immuno Research Laboratories) and 49-69-diamino-29-phenylin-
dole (DAPI, 2 mg/ml, Sigma) solution. The sections were mounted
(Biomedia) and analyzed with confocal microscopy (Nikon).
Delivery of siRNA in vitro and in vivo with the
‘‘T’’chamber coupled to an injection port
The control (scrambled) siRNA or Ndel1 siRNA were
commercially produced according to the manufacturer’s protocol,
with a fluorescent tag placed at the 39 end with Alexa Fluor 488
(20 mM) (Qiagen, Canada). For DRG neurons, siRNAs were
transfected for 24 to 48 hours using HiperFect Transfection
Reagent (Qiagan, Mississauga,ON) according to the manufactur-
er’s instructions. Shortly before transfection, injured DRG neurons
were resuspended in Advanced DMEM (Invitrogen, Burlington,
ON) and seeded on Poly-L-lysine coated coverslips in 6- well
plates. siRNAs were diluted in 100 ml Advanced DMEM without
serum and 16 ml of HiperFect transfection reagent was added to
each of the diluted siRNA. The siRNA complexes were added
dropwise on the cells and the plate was swirled gently to ensure
even distribution of the transfection complexes. Immunofluores-
cence staining was performed according to Nguyen et al. 2004.
For in vivo injections, 6.43 ml of siRNA (2000 ng or 120 nmol) were
mixed with 20 ml HiPerfect Transfection Reagent and 73.57 ml
Ringer’s solution. An injection of 100 ul of siRNA preparations
was administrated to each rat. The use of the ‘‘T’’ chamber
coupled to an injection port has been described previously [33,34].
The siRNAs were directly provided to the sectioned nerve and its
surrounding milieu via the injection port first at 2 hours post-
injury. Repeated injections were performed at 1, 3 and 5 days
post-injury; with harvesting of the above tissues performed at 7
days post-injury.
Supporting Information
Figure S1 No interaction between Ndel1 and Peripherin in
spinal cord and nerves (A) Sucrose gradient demonstrating the
significant co-fractionation of Ndel1 with Vimentin but not
Peripherin in spinal cord and nerves. (B) Ndel1 does not co-
immunoprecipitate with Peripherin and vice-versa in spinal cord
and nerve lysates. HA antibodies were used as control for co-
immunoprecipitations.
Found at: doi:10.1371/journal.pone.0002014.s001 (2.67 MB TIF)
Figure S2 Protein levels 3 and 12 hours after sciatic nerve crush
(A) Quantification graph of levels of Ndel1, Vimentin full length
(FL) or truncated (TR) (in arbitrary units) 3 and 12 hours post
injury in proximal (Prox) and distal (Dist) fragments (n=5 for each
condition). (B) Quantification of Vimentin truncated protein levels
found in Ndel1 co-immunoprecipitates 3 and 12 hours post injury
in proximal (Prox) and distal (Dist) fragments (n=5 for each
condition).
Found at: doi:10.1371/journal.pone.0002014.s002 (5.19 MB TIF)
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